Skip to main content
Haemato AG logo

Haemato AG — Investor Relations & Filings

Ticker · HAEK ISIN · DE000A289VV1 LEI · 529900Q3CGRYVCW7E340 F Wholesale and retail trade
Open in API
Filings indexed 188 across all filing types
Latest filing 2019-02-08 Annual Report
Country DE Germany
Listing F HAEK

About Haemato AG

https://haemato.de/en/start.html

Haemato AG is a pharmaceutical company focused on the specialty pharma market, concentrating on treatments for chronic diseases and high-priced therapies. The company's business activities include the development, acquisition, licensing, and distribution of a product portfolio that comprises innovative patent-protected medicines, biosimilars, and generics. The portfolio also extends to narcotics, including cannabis products, as well as over-the-counter (OTC) products and special cosmetics. Haemato AG's primary therapeutic areas of focus are HIV/AIDS, neurology, oncology, rheumatology, and ophthalmology.

Recent filings

Filing Released Lang Actions
Datum:08.02.2019
Annual Report Classification · 100% confidence The document is a German 'Jahresabschluss' (Annual Financial Statement) for HAEMATO AG for the fiscal year 2017. It contains detailed balance sheets (Aktiva/Passiva), notes to the financial statements (Anhang), and breakdowns of assets, equity, and liabilities. As it provides comprehensive financial statements for a full fiscal year, it is classified as an Annual Report (10-K). FY 2017
2019-02-08 German
Konzernabschluss zum Geschäftsjahr vom 01.01.2017 bis zum 31.12.2017
Annual Report Classification · 100% confidence The document is a comprehensive annual report for HAEMATO AG for the fiscal year 2017. It includes the 'Bericht des Aufsichtsrates' (Supervisory Board Report), 'Zusammengefasster Lagebericht und Konzernlagebericht' (Combined Management Report), and references the 'Konzernabschluss' (Consolidated Financial Statements). It contains detailed financial and operational analysis, management commentary, and governance disclosures. It is clearly a full annual report rather than a summary or announcement. FY 2017
2019-01-29 German
HAEMATO AG: IFRS Third-Quarter 2018 Results
Earnings Release Classification · 100% confidence The document is titled 'HAEMATO AG: IFRS Third-Quarter 2018 Results' and provides key financial figures (sales, EBIT, net income) for the nine-month period ending September 30, 2018, along with Q3 2018 specifics. This content structure—a summary of financial performance for an interim period (not the full year)—is characteristic of an Interim/Quarterly Report. Although it contains some capital structure updates, the primary focus is the period's financial results. It is not a full 10-K, nor is it merely an announcement of a report (RPA), as it contains the actual summarized results. Therefore, the most appropriate classification is Interim / Quarterly Report (IR). 9M 2018
2018-11-20 English
Half-yearly financial statements 2018
Interim / Quarterly Report Classification · 100% confidence The document is a '2018 Half Year Report' for HAEMATO AG. It contains comprehensive financial statements (balance sheet, income statement, cash flow), a management report, and business analysis for the first six months of the fiscal year. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. H1 2018
2018-10-05 English
Half-yearly financial statements 2018
Interim / Quarterly Report Classification · 100% confidence The document is a '2018 Half Year Report' for HAEMATO AG. It contains comprehensive financial statements (balance sheet, income statement, cash flow), a management report, and business analysis for the first six months of the fiscal year. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. H2 2018
2018-10-05 German
HAEMATO AG: Half Year Report 2018
Report Publication Announcement Classification · 99% confidence The document is titled "HAEMATO AG: Half Year Report 2018" and contains key financial highlights (sales, EBIT, profit) for the first half of 2018. It explicitly states, "The Half Year Report of HAEMATO AG is now available at [link]". Since the document is short (1900 chars) and primarily serves to announce the availability of the full report rather than being the comprehensive report itself, it fits the definition of a Report Publication Announcement (RPA). If it were the full report, it would likely be classified as an Interim/Quarterly Report (IR), but the announcement nature points to RPA.
2018-08-24 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.